{"id":1035,"date":"2012-07-01T00:00:11","date_gmt":"2012-07-01T07:00:11","guid":{"rendered":"http:\/\/rhochistj.org\/RhoChiPost\/?p=1035"},"modified":"2014-02-17T22:13:11","modified_gmt":"2014-02-18T05:13:11","slug":"pathophysiology-syndehams-chorea","status":"publish","type":"post","link":"https:\/\/rhochistj.org\/RhoChiPost\/pathophysiology-syndehams-chorea\/","title":{"rendered":"The Pathophysiology of Syndeham\u2019s Chorea"},"content":{"rendered":"<p><span style=\"font-size: 11pt; line-height: 1.5em;\">By: Neal Shah, Co Editor-In-Chief<\/span><\/p>\n<p>&#8211;<\/p>\n<p>Dyskinesias are abnormal, involuntary movement disorders. \u00a0Subsets of dyskinesias include choreas and atheosis. \u00a0Chorea is irregular and sporadic contraction of muscles whereas athetosis involves a twisting and writhing of muscles. \u00a0These two dyskinesias often occur together and are thus termed choreathetosis.<sup>1<\/sup> \u00a0Common conditions which feature choreatheosis are Huntington\u2019s, and Sydenham\u2019s.<sup>2 <\/sup>\u00a0\u00a0Since chorea involves the dopaminic pathway, first generation antipsychotics, anti-epileptic drugs, and levodopa are among the drugs that trigger this dyskinesia.<\/p>\n<p>Huntington\u2019s is a genetic disease that results from an aberrant elongation of the huntingtin protein leading to overexpression of the dopaminic pathway.<sup>3<\/sup> \u00a0Considered the pharmacologic antagonists of Parkinson\u2019s disease, first generation antipsychotics like haloperidol and fluphenazine are shown to ameliorate symptoms of Huntington\u2019s disease.<sup>4<\/sup> \u00a0While tetrabenazine remains the only FDA-approved pharmacological treatment for Huntington\u2019s chorea, there is no true cure for the disease.<sup>4,5<\/sup> \u00a0Tetrabenazine works in a similar fashion as reserpine: it depletes monoamines such as dopamine by inhibiting their incorporation into vesicles. \u00a0Also like reserpine, this agent is linked to depression and suicidal tendencies, and is thus reserved for advanced cases of chorea after other neuroleptic agents have failed.<sup>5.6 <\/sup><\/p>\n<p>Sydenham\u2019s is a lesser-known dyskinesia. \u00a0Unlike Huntington\u2019s, it is relatively cureable and those afflicted usually have complete recovery.<sup>7<\/sup> \u00a0Sydenham\u2019s chorea results from an auto-immune reaction against a prolonged <i>S. pyogenes<\/i> infection, where the body forms antibodies against antigens of the bacteria known as epitopes. \u00a0Similar epitopes are found in the basal ganglia, an area in the brain which controls movements. \u00a0Antibodies then begin to attack the basal ganglia, causing the dyskinetic movements clinically seen with Sydenham\u2019s chorea.<sup>7,8<\/sup> \u00a0Sydenham\u2019s chorea is part of the Rheumatic Fever component of auto-immune reaction against <i>S. pyogenes<\/i> infection, which includes rheumatic heart disease, strept throat, and polyarthritis.<sup>9<\/sup> \u00a0Sydenham\u2019s chorea mainly effects children aged 5\u201413 and has a predisposition to effect more females than males in roughly a 2:1 ratio.<sup>10<\/sup><\/p>\n<p>The treatment for Sydenham\u2019s chorea is empiric against <i>S. pyogenes<\/i>: penicillin or amoxicillin dosed at 500 mg three-to-four times a day for ten days. \u00a0These beta-lactams are relatively inexpensive and show very low resistance rates among <i>S. pyogenes<\/i> strains.<sup>11<\/sup> \u00a0For patients with severe Sydenham\u2019s chorea who are admitted inpatients, a single penicillin G benzathine injection of 600,000\u20131,200,000 units will suffice. \u00a0In penicillin-allergic patients, clindamycin or the macrolides are safe to use and provide similar clinical efficacies. \u00a0These agents are also given for a duration of ten days.<sup>11<\/sup><\/p>\n<p>Other treatments include valproic acid, immunoglobulins, and corticosteroids.<sup>12-13<\/sup> \u00a0The latter two are administered based on the auto-immune component of Sydenham\u2019s chorea. \u00a0Valproic acid is an anticonvulsant that is generally reserved as an alternative treatment.<\/p>\n<p>SOURCES:<\/p>\n<ol>\n<li>NINDS Chorea Information Page. Available at: <a href=\"http:\/\/www.ninds.nih.gov\/disorders\/chorea\/chorea.htm\" class=\"external external_icon\">http:\/\/www.ninds.nih.gov\/disorders\/chorea\/chorea.htm<\/a>. Accessed June 24, 2012.<\/li>\n<li>Chorea. Available at: <a href=\"http:\/\/www.movementdisorders.org\/disorders\/chorea.php\" class=\"external external_icon\">http:\/\/www.movementdisorders.org\/disorders\/chorea.php<\/a>. Accessed June 24, 2012.<\/li>\n<li>Bonelli RM, Beal MF. Huntington&#8217;s disease. <i>Handb Clin Neurol<\/i>. 2012;106:507\u201426.<\/li>\n<li>Pidgeon C, Rickards H. The pathophysiology and pharmacological treatment of Huntington disease. <i>Behav Neurol<\/i>. 2012 Epub ahead of print<a href=\"file:\/\/\/C:\/Users\/T\/Dropbox\/RhoChiNewsletter%20ARCHIVE\/Draft%20Material%20to%20Review\/Volume%201%20-%20Completed\/Issue%2010%20-%20Jul%20-%20Finalized%20-%206-24-12\/Accepted\/Neal%20Sydeham%20Sources%20-%20AMC.docx#_msocom_1\">[NS1]<\/a>\u00a0.<\/li>\n<li>Killoran A, Biglan KM. Therapeutics in Huntington&#8217;s Disease. <i>Curr Treat Options Neurol<\/i>. 2012. [Epub ahead of print].<\/li>\n<li>Scott LJ. Tetrabenazine: for chorea associated with Huntington&#8217;s disease. <i>CNS Drugs<\/i>. 2011;25(12):1073\u201485.<\/li>\n<li>NINDS Sydenham Chorea Information Page. Available at: <a href=\"http:\/\/www.ninds.nih.gov\/disorders\/sydenham\/sydenham.htm\" class=\"external external_icon\">http:\/\/www.ninds.nih.gov\/disorders\/sydenham\/sydenham.htm<\/a>. Accessed June 24, 2012.<\/li>\n<li>Cunningham MW. Streptococcus and rheumatic fever. <i>Curr Opin Rheumatol<\/i>. 2012;24(4):408\u201416.<\/li>\n<li>Rheumatic fever. Available at: <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0004388\/\" class=\"external external_icon\">http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0004388\/<\/a>. Accessed June 24, 2012.<\/li>\n<li>Rheumatic fever. Available at: <a href=\"http:\/\/www.uptodate.com\/contents\/sydenham-chorea\" class=\"external external_icon\">http:\/\/www.uptodate.com\/contents\/sydenham-chorea<\/a>. Accessed June 24, 2012.<\/li>\n<li>Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis. Available at: <a href=\"http:\/\/circ.ahajournals.org\/content\/119\/11\/1541.full\" class=\"external external_icon\">http:\/\/circ.ahajournals.org\/content\/119\/11\/1541.full<\/a>. Accessed June 24, 2012.<\/li>\n<li>Pe\u00f1a J, Mora E, Cardozo J et al. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham&#8217;s chorea: clinical follow-up of 18 patients. <i>Arq Neuropsiquiatr<\/i>. 2002;60(2-B):374\u20147.<\/li>\n<li>Walker KG, Wilmshurst JM. An update on the treatment of Sydenham&#8217;s chorea: the evidence for established and evolving interventions. <i>Ther Adv Neurol Disord<\/i>. 2010 Sep;3(5):301\u20149.<\/li>\n<\/ol>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>By: Neal Shah, Co Editor-In-Chief &#8211; Dyskinesias are abnormal, involuntary movement disorders. \u00a0Subsets of dyskinesias include choreas and atheosis. \u00a0Chorea is irregular and sporadic contraction of muscles whereas athetosis involves a twisting and writhing of muscles. \u00a0These two dyskinesias often occur together and are thus termed choreathetosis.1 \u00a0Common conditions which feature choreatheosis are Huntington\u2019s, and&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,4],"tags":[668,1822,1825,226,343,113,32,543,58,1918,702,85,238,1566,15,2229,2227,29,2232,50,314,39,137,407,96,725,363,1625,255,2252,2123,16,1847,1061],"class_list":["post-1035","post","type-post","status-publish","format-standard","hentry","category-clinical","category-featured","tag-acid","tag-against","tag-agents","tag-amoxicillin","tag-and","tag-attack","tag-bacteria","tag-beta","tag-brain","tag-carbamazepine","tag-children","tag-chorea","tag-clindamycin","tag-complete","tag-disease","tag-drugs","tag-ebola-virus-disease","tag-editor","tag-fda","tag-fever","tag-for","tag-heart","tag-infection","tag-injection","tag-june","tag-mg","tag-of","tag-or","tag-penicillin","tag-symptoms","tag-tetrabenazine","tag-treatment","tag-valproic","tag-with"],"views":4607,"_links":{"self":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts\/1035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/comments?post=1035"}],"version-history":[{"count":0,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts\/1035\/revisions"}],"wp:attachment":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/media?parent=1035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/categories?post=1035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/tags?post=1035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}